Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure

NCT01187836 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: TRV120027
DRUG: Placebo

Sponsor

Trevena Inc.